Aa Aa Aa
  • Investor Information Overview

Corporate Profile
Sucampo Pharmaceuticals, Inc. is a publicly traded (NASDAQ: SCMP) global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and are also considering o  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Up 0.03 (0.45%)
Data as of 09/18/14 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
08/21/14Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for LubiprostonePrinter Friendly Version
08/05/14Sucampo Reports Second Quarter 2014 Financial Results and Corporate UpdatePrinter Friendly Version
07/23/14Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)Printer Friendly Version
07/22/14Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5Printer Friendly Version
Upcoming Events
There are currently no events scheduled.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.